Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Active Biotech in its new issue
Mandate

Vinge advises Active Biotech in its new issue

April 06, 2009

Vinge has advised Active Biotech in its new issue of shares subject to pre-emption rights for the existing shareholders. Under the new issue, which is underwritten in its entirety by the principal shareholders MGA Holding and Nordstjernan, Active Biotech receives approximately SEK 256 million.

Vinge’s team was led by Erik Sjöman who was assisted by, among others, associates Christian Lindhé, Karolina Tjärnberg Jansson and Maria Doeser (tax law advice).

Vinge’s experts provide an insight into Swedish maritime law in the latest edition of International Comparative Legal Guide – Shipping Law 2022

 Vinge’s experts in martime and transport law have again contributed to the Swedish chapter on maritime law in the International Comparative Legal Guides (ICLG).
August 10, 2022

Sanctions update 22 July

 Further to our previous sanctions updates of 25 February, 3 March, 11 March, 16 March , 14 April and June 8, we herewith provide a further update of recent sanctions developments following Russia’s war against Ukraine:
July 26, 2022

A new EU instrument for international procurement (IPI)

 On 17 June 2022, the Council adopted a regulation on a new instrument for international procurement (“IPI”), following the formal adoption of the IPI at the European Parliament plenary session on 9 June 2022. The general objective of the IPI is to create reciprocity in the access to international public procurement markets by enabling the Commission to undertake investigations and adopt measures to open and improve access to third-country public procurement and concession markets.
July 11, 2022